Brokerages expect that DENTSPLY SIRONA Inc. (NASDAQ:XRAY) will post earnings of $0.68 per share for the current quarter, Zacks Investment Research reports. Eight analysts have made estimates for DENTSPLY SIRONA’s earnings, with estimates ranging from $0.64 to $0.84. DENTSPLY SIRONA reported earnings per share of $0.66 during the same quarter last year, which suggests a positive year over year growth rate of 3%. The company is scheduled to announce its next quarterly earnings report on Friday, November 3rd.

According to Zacks, analysts expect that DENTSPLY SIRONA will report full year earnings of $2.69 per share for the current financial year, with EPS estimates ranging from $2.66 to $2.85. For the next year, analysts anticipate that the business will post earnings of $3.04 per share, with EPS estimates ranging from $2.80 to $3.27. Zacks’ EPS averages are a mean average based on a survey of sell-side research firms that that provide coverage for DENTSPLY SIRONA.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.65. The business had revenue of $992.70 million during the quarter, compared to the consensus estimate of $1 billion. DENTSPLY SIRONA had a positive return on equity of 7.24% and a negative net margin of 20.57%. DENTSPLY SIRONA’s quarterly revenue was down 2.9% on a year-over-year basis. During the same period in the prior year, the business posted $0.76 earnings per share.

Several brokerages have recently issued reports on XRAY. BidaskClub downgraded shares of DENTSPLY SIRONA from a “sell” rating to a “strong sell” rating in a research note on Wednesday. Zacks Investment Research downgraded shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research note on Monday, August 14th. HC Wainwright reiterated a “buy” rating and issued a $68.00 target price (down previously from $74.00) on shares of DENTSPLY SIRONA in a research note on Monday, August 14th. TheStreet downgraded shares of DENTSPLY SIRONA from a “b” rating to a “c+” rating in a research note on Wednesday, August 9th. Finally, UBS AG reiterated a “neutral” rating and issued a $59.00 target price (down previously from $62.00) on shares of DENTSPLY SIRONA in a research note on Thursday, August 10th. Three equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and eight have issued a buy rating to the stock. DENTSPLY SIRONA presently has an average rating of “Hold” and a consensus price target of $66.25.

DENTSPLY SIRONA (NASDAQ:XRAY) traded down 0.60% during mid-day trading on Friday, reaching $52.85. The company had a trading volume of 1,573,864 shares. The firm’s market capitalization is $12.13 billion. The firm has a 50-day moving average price of $61.35 and a 200 day moving average price of $62.19. DENTSPLY SIRONA has a 12-month low of $52.73 and a 12-month high of $65.68.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 13th. Investors of record on Friday, September 29th will be given a dividend of $0.0875 per share. The ex-dividend date is Thursday, September 28th. This represents a $0.35 dividend on an annualized basis and a yield of 0.66%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -10.09%.

WARNING: This piece of content was reported by Daily Political and is owned by of Daily Political. If you are viewing this piece of content on another site, it was illegally copied and reposted in violation of US and international copyright & trademark law. The legal version of this piece of content can be read at https://www.dailypolitical.com/2017/08/20/0-68-earnings-per-share-expected-for-dentsply-sirona-inc-xray-this-quarter.html.

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. BlackRock Inc. boosted its stake in shares of DENTSPLY SIRONA by 3,103.7% in the first quarter. BlackRock Inc. now owns 13,891,329 shares of the medical instruments supplier’s stock worth $867,376,000 after buying an additional 13,457,730 shares in the last quarter. Principal Financial Group Inc. boosted its stake in shares of DENTSPLY SIRONA by 1,445.2% in the first quarter. Principal Financial Group Inc. now owns 5,292,885 shares of the medical instruments supplier’s stock worth $330,488,000 after buying an additional 4,950,337 shares in the last quarter. Clearbridge Investments LLC boosted its stake in shares of DENTSPLY SIRONA by 34.6% in the first quarter. Clearbridge Investments LLC now owns 5,258,060 shares of the medical instruments supplier’s stock worth $328,313,000 after buying an additional 1,353,040 shares in the last quarter. Point72 Asset Management L.P. acquired a new stake in shares of DENTSPLY SIRONA during the first quarter worth approximately $64,184,000. Finally, Renaissance Technologies LLC boosted its stake in shares of DENTSPLY SIRONA by 246.0% in the first quarter. Renaissance Technologies LLC now owns 1,044,558 shares of the medical instruments supplier’s stock worth $65,222,000 after buying an additional 742,700 shares in the last quarter. Institutional investors own 95.13% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Get a free copy of the Zacks research report on DENTSPLY SIRONA (XRAY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.